Furthermore, TIC selected by the lung TIC markers ALDH+/CD44+ from HCC827 and the patient-derived lung cancer cell lines, HKUCL2 and HKUCL4, showed higher NFATc2 expression than the ALDH-/CD44- non-TIC counterpart (Figure 2B)(Liu et al., 2013a). The gene discussed is LDHA; the disease is lung carcinoma.